BiotechTube
Home/Ascendo Biotechnology/Dr. Yen‑Ta Lu
DY

Dr. Yen‑Ta Lu

Founder & Chief Scientific Officer

Ascendo Biotechnology

Therapeutic Areas

OncologyImmunology

Ascendo Biotechnology Pipeline

DrugIndicationPhase
ASD141Solid TumorsPhase 1
ASD001Autoimmune Diseases (IBD, SLE)Preclinical